Cytovia.png
Cytovia Therapeutics’ Management to Present at Three Upcoming Conferences in March
March 08, 2021 10:24 ET | Cytovia Therapeutics
CAMBRIDGE, Mass., March 08, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Natural Killer (NK) and Chimeric...
22157.jpg
Global $4.75 Billion CRISPR & Cas Genes Market Analysis 2016-2019 & Forecasts 2020-2027
March 01, 2021 07:14 ET | Research and Markets
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service; By Application; By End Use; and By Region; Segment...
22157.jpg
Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts
February 08, 2021 07:33 ET | Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and...
22157.jpg
Global Cell Therapy Market Report 2020: Market is Expected to Decline from $7.31 Billion in 2019 to $7.2 Billion in 2020 at a CAGR of -1.54%
December 17, 2020 06:13 ET | Research and Markets
Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Cell Therapy...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
December 03, 2020 09:00 ET | Taconic Biosciences
RENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random...
Excision_Logo_Wordmark_Blue+Green.jpg
HIV-Like Virus Eliminated from the Genomes of Primates; Excision BioTherapeutics Advancing the Innovation to Clinical Development
November 30, 2020 14:47 ET | Excision BioTherapeutics
San Francisco, CA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University have successfully edited SIV –...
22157.jpg
Cell Therapy and Gene Therapy Markets, 2030
November 06, 2020 06:28 ET | Research and Markets
Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets" report has been added to ResearchAndMarkets.com's offering. The report examines developments in cell and gene...
22157.jpg
Global $4.88 Bn CRISPR & Cas Genes Market to 2027: Opportunities in the Expanding Gene & Cell Therapy Area & Government Fund In Genomic R&D
September 21, 2020 05:18 ET | Research and Markets
Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Global CRISPR & Cas Genes Market Size, Share & Trends Analysis by Product & Service (Vector-based Cas, DNA-free Cas, Cell Line...
LogicBio-logo-RGB.png
LogicBio Therapeutics Announces SUNRISE Phase 1/2 Clinical Design for LB-001 for the Treatment of Methylmalonic Acidemia in Pediatric Patients
August 10, 2020 06:35 ET | LogicBio Therapeutics
– LogicBio’s First IND Clearance Leveraging GeneRide, an In Vivo Homologous Recombination-based Genome Editing Platform – – Enrollment to Start with Patients as Young as 3 Years Old, De-escalating...
LogicBio-logo-RGB.png
LogicBio Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
August 10, 2020 06:30 ET | LogicBio Therapeutics
LEXINGTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a company dedicated to extending the reach of genetic medicine with...